高活性血蛋白的生物合成通过高效的血红供应皮奇亚帕斯托里斯底盘
Fei Yu1,2,3,4, Xinrui Zhao1,2,3,4, Jingwen Zhou1,2,3,4
1Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 31, 2023
概括
研究人员设计了Pichia pastoris来提高血红素的生产,使得高活性血红蛋白的高效合成能够用于人工肉和生物催化等应用.
科学领域:
- 生物技术是生物技术.
- 微生物工程 微生物工程
- 蛋白质生产 蛋白质生产
背景情况:
- 血蛋白的微生物合成是一个关键的研究领域.
- 皮奇亚牧草是一种用于重组蛋白质生产的常见宿主.
- 有限的血红素供应阻碍了活性血红蛋白的产生.
研究的目的:
- 为了开发一个高效的血供应Pichia pastoris底盘.
- 增强细胞内血红蛋白生物合成,改善血红蛋白的生产.
- 增加重组血蛋白的标位和功能活动.
主要方法:
- 优化了前体合成,并消除了血红蛋白生物合成中的空间分离.
- 利用蛋白质支架组装速度限制酶.
- 抑制了血红素降解途径.
- 选择了全球蛋白的最佳表达策略.
主要成果:
- 建立了一个强大的Pichia pastoris底盘,增强了血供应.
- 成功地产生了高度活跃的血蛋白:猪肌肉蛋白,大豆血红蛋白,玻璃血红蛋白和P450-BM3.
- 已经证明了人工肉,高细胞密度发酵和生物催化剂的潜力.
结论:
- 工程底盘显著改善了血蛋白的生产和活性.
- 该平台在需要高活性血蛋白的各种领域具有广泛的应用.
- 该战略为工业化血蛋白制造提供了一个有前途的方法.
相关概念视频
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


